Old drug tested as new hope against COVID-19
NCT ID NCT05889793
Summary
This study tested whether a low-dose oral medication called emetine could help treat COVID-19 symptoms and prevent severe outcomes like hospitalization. Researchers planned to give participants either emetine or a placebo pill for 10 days to compare results. The trial was terminated early after enrolling only 4 participants, so no conclusions about effectiveness could be reached.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for COVID-19 are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Bharatpur Hospital
Bharatpur, Chitwan, 00000, Nepal
-
Johns Hopkins University, Division of Infectious Diseases
Baltimore, Maryland, 21231, United States
Conditions
Explore the condition pages connected to this study.